Role of Serum Uric Acid Level in Predicting Outcome in Acute Myocardial Infarction
Journal Title: National Journal of Laboratory Medicine - Year 2016, Vol 5, Issue 4
Abstract
Introduction: Acute myocardial infarction (AMI) is one of the leading causes of mortality and morbidity. Various prognostic markers have been used in AMI some of which are expensive and/or not easily available. Aim: To determine the role of serum uric acid levels in predicting short-term outcome in AMI. Materials and Methods: A hospital-based prospective, analytical observational study, in 102 consecutive AMI patients (WHO criteria), ≥ 18 years of age, admitted to the Departments of Medicine and Cardiology. Patients with recurrent myocardial infarction (MI), with additional confounding factors likely to alter serum uric acid levels were excluded. Serum uric acid was measured by using VITROS Uric acid slide method. Statistical Analysis: Unpaired ‘t’ test was used to study association of serum uric acid levels with individual parameters. Unadjusted multivariate logistic regression analysis was used for comparison of variables against in-hospital mortality. A ‘p-value’ <0.05 was considered statistically significant Results: There was a male preponderance (Male:Female = 1.83:1.0) with a mean age of 58.09±13.40 years. Chest pain (73.53%) was the commonest symptom. Anterior-wall was the commonest site (66.67%) and ST-segment elevation MI (STEMI) was the commonest type (55.9%) of MI. One-third (33.3%) of patients had dyslipidemia and over half (57.84%) were hypertensive. Over one-fourth (27.45%) had elevated serum uric acid (>7.0 mg/dl); mean serum uric acid levels were maximum in patients ≥80 years (7.38mg/dl). Mean serum uric acid level was higher in NSTEMI compared to STEMI (5.78mg/ dl vs. 5.59mg/dl; p=0.60). Mean serum uric acid was higher in higher Killip classes (6.58 and 7.38 mg/dl in classes III, IV respectively) compared to lower classes (3.80 & 4.58mg/dl in classes I, II respectively). Higher serum uric acid levels were associated with longer hospital stay (6 days for serum uric acid <4 mg/dl vs 9 days for serum uric acid >7 mg/dl). Overall in-hospital mortality was 9.8%; of which the highest number (70%) had serum uric acid level >7mg/dl (p=0.03). Conclusion: In AMI, patients with a higher Killip class, signifying severe disease, were found to have a higher serum uric acid level. Further, patients with higher serum uric acid had longer hospital stay and significantly higher in-hospital mortality. Serum uric acid may be used as a cheap and effective prognostic indicator in AMI.
Authors and Affiliations
Dr. Prasanta Kumar Bhattacharya, Dr. Mayank Agarwal, Dr. Debdutta Gautom, Dr. Hiranya Saikia
Keywords
Related Articles
- EP ID EP382128
- DOI 10.7860/NJLM/2016/22307:2175
- Views 147
- Downloads 0
Pap Smear Evaluation through Opportunistic Screening Programme in Tertiary Care Hospitals and Rural Mangalore
Introduction: Pap smear cytology enables the cytopathologist to detect and evaluate the degree of cellular alterations present in uterine cervical lesions. Cytopathological analysis of these smears has stood out amongst...
Mucoepidermoid Carcinoma of the Head and Neck: Clinico-Pathologic Study of 12 Cases
Introduction: Mucoepidermoid carcinoma (MEC), one of the most common salivary gland malignancies, but it is rare in children. MEC occurs mainly in the parotid gland, followed by the minor salivary glands. Palate being th...
Parathyroid Adenoma in Child: A Case with Unusual Presentation
Parathyroid adenoma causing hyperparathyroidism occurs mainly in age groups between 50 to 60 years. It is rare in children. Presentation in Paediatric patients with primary hyperparathyroidism is usually with vague sympt...
The Potential of Using VCS Parameters of Neutrophils and Monocytes as an Early Diagnostic Tool in Acute Bacterial Infections
Introduction: Infection and sepsis are known to produce numerical and morphological changes in the leucocytes. Morphological assessment of leucocytes by peripheral blood smear examination is time consuming and more subje...
Metaplastic Carcinoma Breast with Chondroid Differentiation: A Rare Case Report and Review of Literature
Metaplastic carcinoma of the breast is a rare tumour. Though metaplastic carcinoma is by itself a rare entity, however metaplastic carcinoma with chondroid differentiation makes it even rarer. These tumours are ER, PR, H...